SEC Filings TLDR

On October 27, 2025, Thomas M. Lo, EVP and Chief Admin Officer of Cathay General Bancorp, sold 1,000 shares of the company's common stock at a price of $46.8284 per share. Following this transaction, Lo's total ownership in the company stands at 3,000 shares. The transaction was reported in a Form 4 filing with the SEC...

Richard D. Fairbank, Chairman and CEO of Capital One Financial Corp, engaged in multiple transactions involving the company's common stock on October 27, 2025. These transactions included both acquisitions and disposals of shares. Fairbank acquired 53,486 shares at a price of $63.73 per share and disposed of a total of...

Frank McCormick, a director of BridgeBio Pharma, Inc., sold 1,641 shares of common stock on October 27, 2025, at a price of $65 per share. This transaction was executed under a Rule 10b5-1 trading plan adopted on August 28, 2024. Following the sale, McCormick's direct ownership in the company stands at 83,275 shares, w...

On July 18, 2025, the Board of Directors of Brag House Holdings, Inc. granted 100,000 stock options to Jackson DeLu, a director of the company. The options were issued under the company's 2024 Omnibus Incentive Plan. These options are fully vested, immediately exercisable, and will expire on July 18, 2030. The exercise...

On October 27, 2025, Yap Kim Choy, a ten percent owner of Bio Green Med Solution, Inc. (BGMS), sold 120,250 shares of common stock at a price of $2.118 per share. Following this transaction, Yap Kim Choy's total ownership in the company decreased to 264,620 shares. The transaction was reported in a Form 4 filing with t...

On October 27, 2025, Bhaskar Menon, a director of Better Home & Finance Holding Co (BETR), was awarded 666 restricted stock units (RSUs) of Class A Common Stock. Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs will vest on the business day immediately preceding...

David Michael Barse, a director of Better Home & Finance Holding Co, acquired 272 restricted stock units (RSUs) on October 27, 2025. Each RSU represents a contingent right to receive one share of the company's Class A common stock. The RSUs will vest on the business day immediately preceding the company's next annual m...

FMR LLC, a ten percent owner of Beam Therapeutics Inc., reported the disposal of 459 shares of common stock on October 27, 2025, at a price of $26.68 per share. Following this transaction, FMR LLC's direct ownership was reduced to 14 shares. The filing also disclosed that FMR LLC, through its subsidiaries, holds signif...

On October 28, 2025, Abraham Thomas, President of SBC at Byline Bancorp, Inc., sold a total of 23,400 shares of common stock. The shares were sold in two transactions: 3,400 shares at $26.9755 per share and 20,000 shares at $26.8715 per share. Following these transactions, Thomas's total ownership in Byline Bancorp, In...

Philip A. Hodges, Chief Operating Officer of Boston Beer Co Inc, reported significant equity transactions on October 28, 2025. He acquired 13,186 shares of Class A Common stock at $0.00 per share, increasing his total holdings to 46,888 shares. Additionally, he was granted 88,268 stock options with an exercise price of...

On October 27, 2025, Warren E. Buffett and Berkshire Hathaway Inc. reported the sale of 401,514 shares of DaVita Inc. common stock at a price of $135.3558 per share. Following this transaction, they collectively own 31,759,065 shares of DaVita Inc. The shares sold were part of the holdings of Government Employees Insur...

On October 27, 2025, Philip F. Patman Jr., Executive Vice President - Finance of Barnwell Industries, Inc., received several stock awards and incentive stock options. The awards include a stock award and a restricted stock unit award, both granted by the Compensation Committee and the Board of Directors. The restricted...

On October 29, 2025, Amy Elazzouzi, Senior Vice President of Finance at Aura Biosciences, Inc., sold 896 shares of common stock at a price of $6.35 per share. This transaction was conducted to cover tax withholding obligations related to the vesting of restricted stock units and was automatic, not at the discretion of ...

Elisabet de los Pinos, President and Chief Executive Officer of Aura Biosciences, Inc., sold 9,049 shares of common stock on October 29, 2025, at a price of $6.35 per share. The sale was conducted to cover tax withholding obligations related to the vesting of restricted stock units and was automatic, not at her discret...

On October 27, 2025, John C. Malone, a ten percent owner of Atlanta Braves Holdings, Inc., purchased 840 shares of Series A Common Stock at a weighted average price of $41.994 per share. Following this transaction, Malone directly owns 372,547 shares of Series A Common Stock. Additionally, Malone indirectly owns 10,177...

Robert C. Goeltz II, the Chief Financial Officer of Arcus Biosciences, Inc., sold 5,000 shares of common stock on October 28, 2025, at a price of $20 per share. This transaction was executed under a Rule 10b5-1 trading plan adopted on March 7, 2023. Following the sale, Goeltz II owns 92,138 shares of the company's comm...

Amie Thuener O'Toole, VP and Chief Accounting Officer of Alphabet Inc., reported several transactions involving Class C Google Stock Units and Class C Capital Stock on October 25, 2025. The transactions included the vesting of stock units and the withholding of shares to satisfy tax obligations. Specifically, 676 and 2...

Robert I. Kauffman, the Chief Executive Officer and a significant owner of Aldel Financial II Inc., disposed of 12,500 Class B ordinary shares on October 27, 2025. These shares are convertible into Class A ordinary shares on a one-for-one basis at the time of the company's initial business combination, subject to certa...

Peter Early resigned as a director of Aldel Financial II Inc., effective as of October 27, 2025. As part of his resignation, Early transferred 12,500 Class B ordinary shares to Charles Nearburg, his replacement on the Board, for an aggregate purchase price of $54.35. The Class B ordinary shares are convertible into Cla...

On October 27, 2025, Yogesh Jashnani, the Chief Executive Officer of Airsculpt Technologies, Inc., saw the vesting of 56,097 Performance Stock Units (PSUs) as the first of four stock price performance goals was met. This goal required the company's common stock to achieve a 60-day average price equal to or greater than...

Joseph Gebbia, a director and ten percent owner of Airbnb, Inc., sold a significant portion of his Class A Common Stock holdings on October 27, 2025. The transactions were executed under a Rule 10b5-1 trading plan adopted on February 26, 2025. The sales included multiple transactions with weighted average prices rangin...

On October 28, 2025, William J. Pellicciotti Jr., the Principal Accounting Officer of Air Products & Chemicals, Inc., disposed of 303 shares of common stock at a price of $256.03 per share. Following this transaction, Pellicciotti directly owns 3,257 shares of common stock. Additionally, he indirectly owns 27 shares th...

On October 27, 2025, K. Michelle Borninkhof, Senior Vice President & CIO of AutoZone Inc., engaged in several stock transactions. She acquired 300 shares of common stock at $1,519.62 per share and subsequently disposed of 300 shares at $3,775.00 per share. Additionally, she exercised non-qualified stock options for 300...

On October 27, 2025, Sarah Gheuens, Chief Medical Officer of Agios Pharmaceuticals, Inc., engaged in several transactions involving the company's common stock. She acquired 3,302 shares at $25.01 per share and subsequently disposed of the same number of shares at a weighted average price of $43.92. The sale was execute...

William David III, the Chief Financial Officer of Agilysys Inc, sold 6,000 shares of common stock on October 27, 2025, at a weighted average price of $115.55 per share. The shares were sold in multiple transactions at prices ranging from $113.85 to $117.04. Following this transaction, Mr. Wood retains ownership of 41,2...